Vionnie Yu

Vionnie Yu, Ph.D., serves as a Professor at Northeastern University and Vice President at Duality Biologics since August and September 2025, respectively. As the Founder and Principal at Pegasus Consulting, Vionnie provides strategic business insights and scientific expertise to various stakeholders in the pharmaceutical industry. Previously, Vionnie held significant leadership roles, including Executive Director at Kelonia Therapeutics (2023-2025) and Senior Director of Biology at Mersana Therapeutics (2022-2023), where notable achievements included advancing multiple therapeutic programs through preclinical milestones. Vionnie's extensive experience also encompasses principal investigator roles at Novartis (2015-2022), where pioneering CRISPR-based therapies and collaborations with the Bill & Melinda Gates Foundation were achieved. Vionnie's academic foundation includes an Instructor position at Harvard Medical School and advanced degrees from Harvard University and McGill University.